I am Professor of Cardiology at the University of Western Australia (Harry Perkins Institute of Medical Research) and a Consultant Cardiologist at Fiona Stanley Hospital, Murdoch, Perth. Prior to joining UWA in 2017, I worked as a Clinician Scientist and Consultant Cardiologist at the University of Ottawa Heart Institute (UOHI), Canada. My background and training are unique, and I am among the few cardiologists in Australia with advanced (Level 3) multimodality imaging expertise. I hold accreditations in Cardiac CT (Society of Cardiovascular Computed Tomography), echocardiography (American Society of Echocardiography comprehensive examination certification and European Society of Cardiology), Cardiac Magnetic Resonance (Society for Cardiovascular Magnetic Resonance, USA), and Nuclear Cardiology including PET (Certification Board of Nuclear Cardiology, USA).

I completed my PhD in 2010 in non-invasive cardiac imaging at the University of Manchester (UK), with a thesis entitled “A comparison between myocardial contrast echocardiography and radionuclide myocardial perfusion imaging in acute myocardial infarction.” Since then, I have expanded my interests to include novel imaging modalities such as Cardiac CT, PET, and CMR for non-invasive evaluation of coronary artery disease.

Since joining UWA, I have focused on bridging laboratory science with clinical practice in cardiovascular research. I have authored over 300 peer-reviewed publications in high-impact journals including Nature, Annals of Internal Medicine, Chest, JACC Imaging, Metabolism, Journal of Nuclear Cardiology, and AJP – Heart and Circulatory Physiology. My work has been recognised internationally through invited keynote presentations, faculty roles at major conferences, and editorial leadership in leading cardiovascular imaging journals.

My research program has advanced understanding of the link between inflammation and atherosclerosis. By integrating translational medicine with advanced cardiovascular imaging, my team has developed a framework for studying subclinical atherosclerosis across diverse inflammatory conditions. This work has attracted over $33 million in competitive funding from Australia’s leading medical research agencies, including MRFF, NHMRC, FHRI, and the Heart Foundation, reflecting both scientific excellence and global relevance.

Recognising the transformative potential of artificial intelligence in healthcare, I have established one of Australia’s most productive AI–cardiology research hubs in collaboration with UWA’s Department of Computer Science. This work has produced over 50 publications across cardiology and computer science journals and supports a vibrant team of seven PhD students and three post-doctoral fellows. Two of my students have completed their doctorates under my supervision and are emerging as leaders in AI-driven medicine.

Beyond research, I am committed to translating innovations into clinical practice. Through industry collaborations with Siemens, GE, Toshiba, Medtronic, and Philips Healthcare, I have helped accelerate the implementation of novel technologies. As Chief Medical Officer and later Chief Scientific Officer of Artrya Ltd, I led the development of AI algorithms that automate CTCA biomarker assessment, resulting in several international patents and a FDA/TGA-approved product that is transforming cardiac diagnostics. Artrya’s listing on the ASX and market valuation exceeding $250 million underscore the impact of this work.

In addition, I co-founded Luddub Pty Ltd with RMIT researchers. This venture was recognised as a finalist for the WA Innovator of the Year award and received prestigious FHRI funding. These experiences reflect my commitment to mentoring the next generation of clinician-innovators while building platforms that translate cardiovascular science into real-world impact.

My leadership in education and research has been recognised through both national and international appointments. I served as Scientific Chair of the 2024 Cardiac Society of Australia and New Zealand (CSANZ) Annual Conference and currently serve as the CSANZ Imaging WA Representative, Chair of the Conjoint Committee for Recognition of Training in CT Coronary Angiography in Australia and New Zealand, a member of the Society of Cardiovascular Computed Tomography (USA) Education Committee, and a CSANZ Board Member representing Western Australia.